Bayer CropScience Q4 FY18 earnings call: Revenue & Margins
Q4 FY18 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #15 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
Bayer CropScience Ltd Q4 FY18 key numbers
- Revenue
- Sales for Bayer Global Q1 2018 were €9,138 million.
As stated in Bayer CropScience Ltd's Q4 FY18 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.
Based on Bayer CropScience Ltd's Q4 FY18 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Sales for Bayer Global Q1 2018 were €9,138 million. EBITDA (before special items) for Bayer Global in Q1 2018: - Crop Science segment: €2,861 million, down 1.0% year-on-year (currency- and portfolio-adjusted) - Operating margin: - Crop Science segment declined by 6.5% in Q1 2018 year-on-year - Profit (PAT) for Financial Year 2017-18 (not quarter): - Profit Before Tax (PBT) decreased 9% over previous year; figures: PY 4,479 Mio INR, CY 4,038 Mio INR
From Bayer CropScience Ltd's Q4 FY18 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Sales for Bayer Global Q1 2018 were €9,138 million.
- Year-on-year change (currency- and portfolio-adjusted):
- Consumer Health: -2.2%
- Crop Science: -1.0%
- Animal Health: +3.0%
- Pharmaceuticals: +2.9%
- EBITDA changes year-on-year:
- Pharmaceuticals: -5.8%
- Consumer Health: -20.2%
- Crop Science: -6.5%
- Animal Health: +3.0%
- Income overview for FY 2017-18:
- Total revenue decreased from INR 30,185 million (PY) to INR 27,878 million (CY).
- Exports contribution to revenue decreased from 14% to 9%.
- Domestic contribution increased from 81% to 86%.
- Outlook (Page 27 & 31):
- Positive outlook for 2018-19 based on good monsoon forecast.
- Expectation of positive commodity prices in 2018.
2 more points from Bayer CropScience Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Bayer CropScience Ltd's call on order book
Create a free account to keep reading this call
Bayer CropScience Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bayer CropScience's management said in earlier quarters
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Insecticides IndiaGood growth2
- Anya Polytech &Good growth1
- Madhya Bharat Agro ProductsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Bayer CropScience Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Bayer CropScience Ltd Q4 FY18 results?
Sales for Bayer Global Q1 2018 were €9,138 million. EBITDA (before special items) for Bayer Global in Q1 2018: - Crop Science segment: €2,861 million, down 1.0% year-on-year (currency- and portfolio-adjusted) - Operating margin: - Crop Science segment declined by 6.5% in Q1 2018 year-on-year - Profit (PAT) for Financial Year 2017-18 (not quarter): - Profit Before Tax (PBT) decreased 9% over previous year; figures: PY 4,479 Mio INR, CY 4,038 Mio INR
What is Bayer CropScience Ltd share price analysis?
Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
